Study shows being an elite male athlete protects against type 2 diabetes in later life

A study of almost 400 former elite male athletes shows that former status as an elite athlete reduces the risk of developing type 2 diabetes in later life by 28%. The research appears in Diabetologia, the journal of the European Association for the Study of Diabetes (EASD), and is by Dr Merja Laine, University of Helsinki, Helsinki, Finland, and colleagues.

The study of Finnish male athletes follows-up on work that began in 1985, when a questionnaire was sent to 1,518 former athletes and 1,010 controls, and further questionnaires were sent out in1995 and 2001. In 2008, an invitation to participate in a clinical study was sent to all former athletes who were still alive (747, of whom 392 participated) and controls (436, of whom 207 participated) and had answered at least one of the previous questionnaires. The clinical study included a physical examination, laboratory tests and questionnaires.

The former athletes were divided into three groups based on their active career sport: endurance, mixed and power sports. Participants without a history of (n=537) underwent an oral glucose tolerance test (75g of glucose delivered over 2 hours). Current volume of leisure-time physical activity (LTPA) was determined by self-reported questionnaires and expressed in metabolic equivalent hours. Data on reimbursable diabetes medication from participants and non-participants were obtained from a central Finnish register.

The researchers found that being a former elite athlete reduced the risk of developing by a statistically significant 28%. However, this reduction varied among the different sports categories: the risk reduction was 61% for those who had had careers in endurance sports (a statistically significant finding) while for mixed sports the reduction was 21% and power was 23% (both not statistically significant).

The risk of type 2 diabetes decreased with increased LTPA volume, by 2% per 1 MET-h per week. The former also had a 42% lower risk of impaired glucose tolerance (IGT), a precursor state to full blown diabetes. The authors say: "With ageing, the former maintained their physically active lifestyle better than the controls." They conclude: "A former career as an elite athlete protected from both type 2 diabetes and IGT in later life. In addition, the volume of current leisure-time physical activity was inversely associated with the prevalence of type 2 diabetes."

add to favorites email to friend print save as pdf

Related Stories

Do elite 'power sport' athletes have a genetic advantage?

Sep 25, 2013

A specific gene variant is more frequent among elite athletes in power sports, reports a study in the October issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and ...

Olympians say poor oral health is impairing performance

Sep 30, 2013

Many of the elite sportsmen and women who competed at the London 2012 Olympic Games had poor levels of oral health similar to those experienced by the most disadvantaged populations. 18 per cent of athletes surveyed said ...

Recommended for you

Blood glucose levels set for achieving HbA1c targets

Apr 11, 2014

(HealthDay)—The average self-monitored blood glucose (SMBG) concentrations needed at premeal, postmeal, and bedtime have been established to achieve a range of hemoglobin A1c (HbA1c) targets, according ...

Women with diabetes less likely to have a mammogram

Apr 11, 2014

Women with diabetes are 14 per cent less likely to be screened for breast cancer compared to women without diabetes, according to a study by researchers at the Institute for Clinical Evaluative Sciences (ICES) and Women's ...

Nonalcoholic fatty liver disease linked to CKD in T1DM

Apr 09, 2014

(HealthDay)—For patients with type 1 diabetes, nonalcoholic fatty liver disease (NAFLD) is independently associated with the risk of incident chronic kidney disease (CKD), according to a study published ...

Common diabetes treatment could extend hypoglycaemia

Apr 08, 2014

(Medical Xpress)—Researchers at the University of Adelaide have discovered that a common treatment for people with type 2 diabetes could cause longer-than-normal periods of the low blood sugar reaction hypoglycaemia, which ...

User comments